Reduced hemodialysis adequacy after hemoglobin normalization with epoetin

Journal of Nephrology

Volumn 18, Issue 1, 2005, Pages 80-85

  Furuland, Hans ^a   Linde, Torbjörn ^a   Wikström, Björn ^a   Danielson, Bo G ^b  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b Renapharma AB   (Sweden)

Author keywords

Anemia; End stage renal failure; Epoetin; Erythropoietin; Hemodialysis adequacy; Hemoglobin; Kt V

Indexed keywords

CALCIUM ACETATE; CALCIUM CARBONATE; HEMOGLOBIN; PHOSPHATE; POLYSTYRENESULFONATE SODIUM; POTASSIUM; RECOMBINANT ERYTHROPOIETIN; UREA; ANTIANEMIC AGENT;

ADULT; AGED; ANEMIA; ANGINA PECTORIS; ARTICLE; BLOOD VISCOSITY; CHOLECYSTECTOMY; CLEARANCE; CLINICAL ARTICLE; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GRAFT FAILURE; HEART ATRIUM FIBRILLATION; HEMODIALYSIS; HEMOGLOBIN DETERMINATION; HUMAN; HYPERTENSION; KNEE INJURY; MALE; PHOSPHATE BLOOD LEVEL; POTASSIUM BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SEPSIS; STATISTICAL SIGNIFICANCE; UREA BLOOD LEVEL; VERTIGO; DOSE RESPONSE; METABOLISM; MIDDLE AGED; RENAL REPLACEMENT THERAPY; STANDARD;

AGED; DOSE-RESPONSE RELATIONSHIP, DRUG; EPOETIN ALFA; FEMALE; HEMATINICS; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; RENAL DIALYSIS;

EID: 16844385996     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Lundin AP, Akerman MJ, Chesler RM, Delano BG, Goldberg N, Stein RA, Friedman RA. Exercise in hemodialysis patients after treatment with recombinant human erythropoietin. Nephron 1991; 58: 315-9.
2. Beusterien KM, Nissenson AR, Port FK, Kelly M, Steinwald B, Ware JE, Jr. The effects of recombinant human erythropoietin on functional health and well-being in chronic dialysis patients. J Am Soc Nephrol 1996; 7: 763-73.
3. Lowrie EG, Laird NM, Parker TF, Sargent JA. Effect of the hemodialysis prescription of patient morbidity: report from the National Cooperative Dialysis Study. N Engl J Med 1981; 305: 1176-81.
4. Collins AJ, Ma JZ, Umen A, Keshaviah P. Urea index and other predictors of hemodialysis patient survival. Am J Kidney Dis 1994; 23: 272-82.
5. Parker TF, 3rd, Husni L, Huang W, Lew N, Lowrie EG. Survival of hemodialysis patients in the United States is improved with a greater quantity of dialysis. Am J Kidney Dis 1994; 23: 670-80.
6. Eknoyan G, Levin N. NKF-K/DOQI Clinical Practice Guidelines: Update 2000. Foreword. Am J Kidney Dis 2001; 37 (suppl 1): S5-6.
7. Section II. Haemodialysis adequacy. Nephrol Dial Transplant 2002; 17 (suppl 7): S16-31.
8. Clark WR, Shinaberger JH. Effect of dialysate-side mass transfer resistance on small solute removal in hemodialysis. Blood Purif 2000; 18: 260-3.
9. Schaefer RM, Schaefer L. Treatment with erythropoietin and loss of dialyser clearance. Nephrol Dial Transplant 1996; 11 (suppl 2): S81-2.
10. Nand N, Arya S, Mahajan SK, Sharma M, Aggarwal HK, Kumar P. The effect of hematocrit on the efficiency of hemodialysis in cases of chronic renal failure. Indian J Med Sci 1996; 50: 29-33.
11. Lim VS, Flanigan MJ, Fangman J. Effect of hematocrit on solute removal during high efficiency hemodialysis. Kidney Int 1990; 37: 1557-62.
12. Furuland H, Linde T, Ahlmen J, Christensson A, Strombom U, Danielson BG. A randomized controlled trial of haemoglobin normalization with epoetin alfa in pre-dialysis and dialysis patients. Nephrol Dial Transplant 2003; 18: 353-61.
13. Daugirdas JT. Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. J Am Soc Nephrol 1993; 4: 1205-13.
14. Daugirdas JT, Depner TA, Gotch FA, Greene T, Keshaviah P, Levin NW, Schulman G. Comparison of methods to predict equilibrated Kt/V in the HEMO Pilot Study. Kidney Int 1997; 52: 1395-405.
15. Gotch FA, Sargent JA. A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int 1985; 28: 526-34.
16. Schön S, Ekberg H, Wikström B, Odén A, Ahlmén J. Renal replacement therapy in Sweden. Scand J Urol Nephrol 2004; 38: 332-9.
17. Movilli E, Cancarini GC, Mombelloni S, Feller P, Ravelli M, Maiorca R. The role of hematocrit in efficiency of dialysis. Blood Purif 1990; 8: 183-9.
18. Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, Allon M, Bailey J, Delmez JA, Depner TA, Dwyer JT, Levey AS, Levin NW, Milford E, Ornt DB, Rocco MV, Schulman G, Schwab SJ, Teehan BP, Toto R. Hemodialysis (HEMO) Study Group. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 2002; 347: 2010-9.